Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Magdalena Balp

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|May 23, 2016
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous UrticariaJonathan Graham, Doreen McBride, Donald Stull, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|August 25, 2022
The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United StatesAndreas Geier, Sabina Heinz, Maria-Magdalena Balp, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosisLynda C Doward, Matthew Breckons, Maria-Magdalena Balp, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2012
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosisKavi J Littlewood, Kyoko Higashi, Jeroen P Jansen, et al.
Journal of Comparative Effectiveness Research|March 19, 2026
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatmentAustin Kulasekararaj, Phillip Scheinberg, Maria-Magdalena Balp, et al.
BMC Gastroenterology|April 5, 2023
The burden of nonalcoholic steatohepatitis (NASH) in the United StatesElliot B Tapper, Nancy Krieger, Raymond Przybysz, et al.
Allergy and Asthma Proceedings|October 29, 2025
Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticariaDiane Whalley, Maria-Magdalena Balp, Christel Naujoks, et al.
International Journal of Hematology|February 10, 2026
Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world surveyMasatoshi Sakurai, Yasutaka Ueda, Naoshi Obara, et al.
Scientific Reports|April 5, 2023
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
Journal of the American Medical Informatics Association : JAMIA|March 8, 2021
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitisMatt Docherty, Stephane A Regnier, Gorana Capkun, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|May 23, 2016
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous UrticariaJonathan Graham, Doreen McBride, Donald Stull, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|August 25, 2022
The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United StatesAndreas Geier, Sabina Heinz, Maria-Magdalena Balp, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosisLynda C Doward, Matthew Breckons, Maria-Magdalena Balp, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2012
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosisKavi J Littlewood, Kyoko Higashi, Jeroen P Jansen, et al.
Journal of Comparative Effectiveness Research|March 19, 2026
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatmentAustin Kulasekararaj, Phillip Scheinberg, Maria-Magdalena Balp, et al.
BMC Gastroenterology|April 5, 2023
The burden of nonalcoholic steatohepatitis (NASH) in the United StatesElliot B Tapper, Nancy Krieger, Raymond Przybysz, et al.
Allergy and Asthma Proceedings|October 29, 2025
Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticariaDiane Whalley, Maria-Magdalena Balp, Christel Naujoks, et al.
International Journal of Hematology|February 10, 2026
Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world surveyMasatoshi Sakurai, Yasutaka Ueda, Naoshi Obara, et al.
Scientific Reports|April 5, 2023
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
Journal of the American Medical Informatics Association : JAMIA|March 8, 2021
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitisMatt Docherty, Stephane A Regnier, Gorana Capkun, et al.
Pageof 6